|
FR901228A
(fr)
|
1943-01-16 |
1945-07-20 |
Deutsche Edelstahlwerke Ag |
Système d'aimant à entrefer annulaire
|
|
US5260223A
(en)
*
|
1986-07-03 |
1993-11-09 |
President & Fellows Of Harvard College |
Methods for detection of human gamma, γ T cell receptor
|
|
CA2018248A1
(en)
|
1989-06-07 |
1990-12-07 |
Clyde W. Shearman |
Monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5350674A
(en)
|
1992-09-04 |
1994-09-27 |
Becton, Dickinson And Company |
Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof
|
|
FR2698880B1
(fr)
|
1992-11-25 |
1995-02-24 |
Inst Nat Sante Rech Med |
Procédé de production de récepteurs T solubles, produits ainsi obtenus et leur utilisation dans des compositions diagnostiques ou thérapeutiques.
|
|
US5962271A
(en)
|
1996-01-03 |
1999-10-05 |
Cloutech Laboratories, Inc. |
Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end
|
|
US6207455B1
(en)
|
1997-05-01 |
2001-03-27 |
Lung-Ji Chang |
Lentiviral vectors
|
|
KR100556864B1
(ko)
|
1997-05-13 |
2006-03-10 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
렌티바이러스-기원 유전자 전달 벡터
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
US6218181B1
(en)
|
1998-03-18 |
2001-04-17 |
The Salk Institute For Biological Studies |
Retroviral packaging cell line
|
|
GB9810099D0
(en)
*
|
1998-05-11 |
1998-07-08 |
Isis Innovation |
Novel molecule and diagnostic method
|
|
WO1999060120A2
(en)
|
1998-05-19 |
1999-11-25 |
Avidex Limited |
Soluble t cell receptor
|
|
DE19909769A1
(de)
|
1999-03-05 |
2000-09-07 |
Bundesrepublik Deutschland Let |
Von SIVagm abgeleitete lentivirale Vektoren, Verfahren zu ihrer Herstellung und ihre Verwendung zur Genübertragung in Säugerzellen
|
|
JP2001332430A
(ja)
|
2000-05-22 |
2001-11-30 |
Murata Mfg Co Ltd |
トランス
|
|
AU2001292842A1
(en)
|
2000-09-19 |
2002-04-02 |
Diadexus, Inc. |
Compositions and methods relating to prostate specific genes and proteins
|
|
KR100669065B1
(ko)
*
|
2001-04-03 |
2007-01-15 |
다카라 바이오 가부시키가이샤 |
세포상해성 ｔ 림프구
|
|
US6905827B2
(en)
*
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
US20030175212A1
(en)
|
2002-01-10 |
2003-09-18 |
O'brien Rebecca L. |
Use of soluble gammadelta T cell receptors for regulating T cell function
|
|
MXPA05001933A
(es)
|
2002-08-19 |
2005-04-28 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumores.
|
|
WO2005051988A2
(en)
*
|
2003-03-03 |
2005-06-09 |
Genentech, Inc. |
Compositions and methods for the treatment of systemic lupus erythematosis
|
|
US7892745B2
(en)
*
|
2003-04-24 |
2011-02-22 |
Xdx, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
JP4516916B2
(ja)
*
|
2003-07-11 |
2010-08-04 |
昇志 佐藤 |
リビン由来のｈｌａ−ａ２４結合性癌抗原ペプチド
|
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US20050249743A1
(en)
*
|
2004-01-12 |
2005-11-10 |
Thierry Boon-Falleur |
Isolated peptides which bind to HLA-A24 molecules and uses thereof
|
|
US20050255105A1
(en)
|
2004-03-22 |
2005-11-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Severe myelin deficits induced by self-reactive gamma delta T cells
|
|
AU2005250408B2
(en)
|
2004-05-27 |
2010-09-23 |
The Trustees Of The University Of Pennsylvania |
Novel artificial antigen presenting cells and uses therefor
|
|
WO2006026051A2
(en)
*
|
2004-08-03 |
2006-03-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selections of genes and methods of using the same for diagnosis, prognosis and for targeting the therapy of neuroblastoma
|
|
GB0425732D0
(en)
|
2004-11-23 |
2004-12-22 |
Avidex Ltd |
Gamma-delta t cell receptors
|
|
GB0506760D0
(en)
*
|
2005-04-01 |
2005-05-11 |
Avidex Ltd |
High affinity HIV TCRS
|
|
EP1941028A2
(en)
|
2005-08-08 |
2008-07-09 |
Fondazione Centro San Raffaele Del Monte Tabor |
Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes.
|
|
DE602005020046D1
(de)
*
|
2005-09-05 |
2010-04-29 |
Immatics Biotechnologies Gmbh |
Tumor-assoziierte Peptide, welche an unterschiedliche menschliche Leukozytenantigene der Klasse II binden
|
|
EP1945246A4
(en)
*
|
2005-09-22 |
2009-03-11 |
Irun R Cohen |
IMMUNOGENIC FRAGMENTS OF CONSTANT DOMAINS OF THE T CELL RECEPTOR AND PEPTIDES DERIVED THEREFROM
|
|
US20080131415A1
(en)
|
2006-11-30 |
2008-06-05 |
Riddell Stanley R |
Adoptive transfer of cd8 + t cell clones derived from central memory cells
|
|
WO2009136874A1
(en)
|
2008-05-09 |
2009-11-12 |
Agency For Science, Technology And Research |
Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof
|
|
ES2394180T3
(es)
*
|
2008-11-24 |
2013-01-23 |
Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt Gmbh |
Receptor de células T de alta afinidad y uso del mismo
|
|
WO2010087335A1
(ja)
|
2009-01-27 |
2010-08-05 |
学校法人産業医科大学 |
Ｔ細胞抗原受容体遺伝子、受容体α鎖及びβ鎖発現用ベクター並びに細胞障害性Ｔ細胞
|
|
ES2882916T3
(es)
|
2009-11-02 |
2021-12-03 |
Univ Emory |
Inmunoterapia resistente a medicamentos para tratamiento de un cáncer
|
|
CN102453701B
(zh)
|
2010-10-26 |
2014-08-13 |
中国医学科学院基础医学研究所 |
基因修饰CDR3δ移植型γδT淋巴细胞及其抑癌用途
|
|
US20150353643A1
(en)
|
2013-09-24 |
2015-12-10 |
Universite De La Mediterranee - Aix-Marseille Ii |
Anti-cd277 antibodies and uses thereof
|
|
JP5955871B2
(ja)
|
2011-03-17 |
2016-07-20 |
ミルテニイ バイオテック ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｔｃｒアルファ／ベータを枯渇させた細胞調製物
|
|
CN102532269B
(zh)
*
|
2011-05-16 |
2014-07-09 |
中国医学科学院基础医学研究所 |
γδT淋巴细胞中δ1链互补决定域3的优势序列及其TCR受体转染细胞与应用
|
|
CN103635573B
(zh)
|
2011-05-19 |
2016-05-11 |
分子医学研究所 |
包含γδT细胞的淋巴细胞系、其组合物及生产方法
|
|
EA201490364A1
(ru)
|
2011-07-29 |
2014-08-29 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Костимулирующие рецепторы-переключатели
|
|
CN104334741B
(zh)
|
2012-03-28 |
2018-08-17 |
歌德塔有限公司 |
组合的γ9δ2T细胞受体链交换
|
|
ES2824024T3
(es)
|
2012-10-10 |
2021-05-11 |
Sangamo Therapeutics Inc |
Compuestos modificadores de células T y usos de los mismos
|
|
WO2014179202A1
(en)
*
|
2013-05-02 |
2014-11-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for diagnosis of celiac disease
|
|
WO2015063069A1
(en)
*
|
2013-10-28 |
2015-05-07 |
Benjamin Felder |
Chimeric antigen receptors with antigen binding domains derived from gamma delta t cell receptors
|
|
JP6164759B2
(ja)
*
|
2013-11-21 |
2017-07-19 |
Ｒｅｐｅｒｔｏｉｒｅ Ｇｅｎｅｓｉｓ株式会社 |
Ｔ細胞受容体およびｂ細胞受容体レパトアの解析システムならびにその治療および診断への利用
|
|
RS66199B1
(sr)
|
2014-02-04 |
2024-12-31 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services |
Metode za proizvodnju autolognih t ćelija koje su korisne za lečenje b ćelijskih maligniteta i drugih karcinoma i njihove kompozicije
|
|
JP6894702B2
(ja)
*
|
2014-05-13 |
2021-06-30 |
中外製薬株式会社 |
免疫抑制機能を有する細胞に対するｔ細胞リダイレクト抗原結合分子
|
|
WO2016195086A1
(ja)
|
2015-06-05 |
2016-12-08 |
医療法人社団 滉志会 |
アレルギー性疾患の治療薬
|
|
DK3328894T3
(en)
|
2015-08-06 |
2019-02-04 |
Agency Science Tech & Res |
IL2RBETA / COMMON GAMMA CHAIN ANTIBODIES
|
|
MA44907A
(fr)
|
2015-09-11 |
2018-07-18 |
Agenus Inc |
Cellules hôtes génétiquement modifiées et leurs procédés d'utilisation
|
|
CN105296431B
(zh)
*
|
2015-11-26 |
2018-10-09 |
北京佳德和细胞治疗技术有限公司 |
肿瘤结合特异性γδTCR基因修饰的αβT细胞及其抑癌用途
|
|
US12297427B2
(en)
|
2015-12-04 |
2025-05-13 |
St. Jude Children's Research Hospital, Inc. |
Cloning and expression system for T-cell receptors
|
|
EP3454870A4
(en)
|
2016-05-12 |
2020-03-04 |
Adicet Bio Inc. |
METHOD FOR SELECTIVE EXPANSION OF GAMMA DELTA T CELL POPULATIONS AND COMPOSITIONS THEREOF
|
|
WO2017201019A1
(en)
|
2016-05-17 |
2017-11-23 |
Chimera Bioengineering, Inc. |
Methods for making novel antigen binding domains
|
|
EP4099015A1
(en)
|
2016-06-10 |
2022-12-07 |
Gadeta B.V. |
Novel method for identifying deltat-cell (or gammat-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective response
|
|
MX2019006423A
(es)
|
2016-12-02 |
2019-08-22 |
Rubius Therapeutics Inc |
Composiciones y metodos relacionados con sistemas de celulas para penetrar en tumores solidos.
|
|
CN110462024B
(zh)
*
|
2017-03-07 |
2024-08-09 |
巴塞尔大学 |
用于癌症免疫疗法的mr1限制性t细胞受体
|
|
AU2018268087B2
(en)
|
2017-05-18 |
2022-03-17 |
Umc Utrecht Holding B.V. |
Compositions and methods for cell targeting therapies
|
|
WO2019219979A1
(en)
|
2018-05-18 |
2019-11-21 |
Umc Utrecht Holding B.V. |
Compositions and methods for cell targeting therapies
|